Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
NVIDIA
NVDA
|
$3.17B |
| 2 |
Ginkgo Bioworks
DNA
|
$1.05B |
| 3 |
Peloton Interactive
PTON
|
$691M |
| 4 |
DoorDash
DASH
|
$456M |
| 5 |
Certara
CERT
|
$393M |
Top Sells
| 1 |
Alibaba
BABA
|
$2.33B |
| 2 |
Tesla
TSLA
|
$1.55B |
| 3 |
Moderna
MRNA
|
$1.41B |
| 4 |
Amazon
AMZN
|
$884M |
| 5 |
NetEase
NTES
|
$692M |
Sector Composition
| 1 | Consumer Discretionary | 27.71% |
| 2 | Healthcare | 26.02% |
| 3 | Technology | 19.32% |
| 4 | Communication Services | 12.04% |
| 5 | Financials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Mercury Systems
MRCY
$4.05B
| – | – | -205 | Closed | -$14K |
|
502
Annaly Capital Management
NLY
$13.6B
| – | – | -7,446 | Closed | -$66K |
|
503
Trimble
TRMB
$19.2B
| – | – | -359 | Closed | -$29K |
|
504
Invesco Senior Income Trust
VVR
$561M
| – | – | -3,195,695 | Closed | -$14.3M |
|
505
Wabtec
WAB
$33.1B
| – | – | -3,660,619 | Closed | -$301M |
|
|
CLVS
506
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – | -92 | Closed | -$1K |
|
|
MDP
507
DELISTED
Meredith Corporation
MDP
| – | – | -293 | Closed | -$13K |
|
|
MDLA
508
DELISTED
Medallia, Inc.
MDLA
| – | – | -542 | Closed | -$18K |
|
|
PFPT
509
DELISTED
Proofpoint, Inc.
PFPT
| – | – | -144 | Closed | -$25K |
|